Detalhe da pesquisa
1.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31330065
2.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30536609
3.
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
J Cell Physiol
; 233(3): 2313-2323, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28710865
4.
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
BMC Cancer
; 17(1): 101, 2017 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28166748
5.
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.
J Cell Physiol
; 231(5): 986-91, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26449308
6.
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
Breast Cancer Res Treat
; 147(3): 599-607, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25234842
7.
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.
Ann Surg Oncol
; 21(5): 1575-82, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24522992
8.
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting.
Cells
; 10(7)2021 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34359855
9.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Ther Adv Med Oncol
; 13: 17588359211059873, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-35173816
10.
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression.
Case Rep Oncol Med
; 2019: 1018492, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31355032
11.
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Breast
; 44: 33-38, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30611095
12.
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
J Cancer Res Clin Oncol
; 145(9): 2365-2373, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31280347
13.
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
Ther Adv Med Oncol
; 11: 1758835919853192, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31452691
14.
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Cancer Biol Ther
; 20(2): 192-200, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30403909
15.
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials.
J Clin Med
; 7(12)2018 Dec 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30545122
16.
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage.
Breast
; 32: 79-86, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28064072
17.
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting.
Oncotarget
; 8(40): 69025-69037, 2017 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28978178
18.
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial.
Oncotarget
; 8(33): 54528-54536, 2017 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28903361
19.
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study.
Sci Rep
; 7(1): 10597, 2017 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28878375
20.
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.
Oncotarget
; 8(34): 56921-56931, 2017 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28915642